Skip to main content
logo
Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
42.24
-0.40 (-0.94%)
Aug 14, 2025, 2:50 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Treatment of Central Nervous System Diseases
661.82M
Log In
Log In
Log In
Log In
Upgrade
Treatment of Central Nervous System Diseases Growth
8.94%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
661.82M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
8.94%
Log In
Log In
Log In
Log In
Upgrade